HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

trichloronitritodiammineplatinum(IV)

has antineoplastic activity; structure in first source

Also Known As:

(PtCl3(NO2)(NH3)2); CPA-7 cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Platinum Compounds: 758
  - trichloronitritodiammineplatinum(IV): 1
- Chlorine Compounds: 8
  - trichloronitritodiammineplatinum(IV): 1

Experts

1.	Appelman, Henry: 1 article (06/2014)
2.	Assi, Hikmat H: 1 article (06/2014)
3.	Castro, Maria G: 1 article (06/2014)
4.	Doherty, Robert: 1 article (06/2014)
5.	Hoeschele, James D: 1 article (06/2014)
6.	Lowenstein, Pedro R: 1 article (06/2014)
7.	Mikkelsen, Tom: 1 article (06/2014)
8.	Paran, Chris: 1 article (06/2014)
9.	Petruzzella, Emanuele: 1 article (06/2014)
10.	Raptis, Leda: 1 article (06/2014)

Related Diseases

1.	Glioma (Gliomas) 06/01/2014 - "To this end, we evaluated the STAT3-inhibitory activities of three compounds (CPA-7 [trichloronitritodiammineplatinum(IV)], WP1066 [(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide, C17H14BrN3O], and ML116 [4-benzyl-1-{thieno[2,3-d]pyrimidin-4-yl}piperidine, C18H19N3S]) in cultured rodent and human glioma cells, including GBM cancer stem cells. "

Related Drugs and Biologics

1.	WP1066
2.	piperidine